Ekso Bionics Holdings, Inc. (EKSO) Q4 2024 Annual Earnings
EKSO·Reported March 3, 2025·After market close
Ekso Bionics Holdings, Inc. reported Q4 2024 revenue of $5.1M, beat analyst consensus of $4.8M by $290.0K. Diluted EPS came in at $-0.14, missed the $-0.07 consensus by $0.07.
Revenue
$5.1Mbeat by $290.0K
Consensus: $4.8MDiluted EPS
$-0.14missed by $0.07
Consensus: $-0.07
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Ekso Bionics Holdings, Inc.'s Q4 2024 earnings report.
Ekso Bionics Holdings, Inc. (EKSO) reported Q4 2024 earnings on March 3, 2025 after market close.
Ekso Bionics Holdings, Inc. reported revenue of $5.1M and diluted EPS of $-0.14 for Q4 2024.
Revenue beat the consensus estimate of $4.8M by $290.0K. EPS missed the consensus estimate of $-0.07 by $0.07.
You can read the 10-K periodic report (0001437749-25-005913) directly on SEC EDGAR. The filing index links above go to sec.gov.